Morgan Stanley
ASXC

Morgan Stanley’s Asensus Surgical, Inc. ASXC Stock Holding History

Morgan Stanley’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100,053
Closed -$33.3K – 8096
2024
Q2 		$33.3K Sell
100,053
-17,208
-15% -$4.64K ﹤0.01% 6299
2024
Q1 		$27K Sell
117,261
-250,373
-68% -$72.7K ﹤0.01% 6409
2023
Q4 		$117K Buy
367,634
+163,834
+80% +$42.2K ﹤0.01% 6111
2023
Q3 		$55K Buy
203,800
+61,663
+43% +$22.4K ﹤0.01% 6129
2023
Q2 		$71.8K Buy
142,137
+12,987
+10% +$7.76K ﹤0.01% 6075
2023
Q1 		$85K Sell
129,150
-291,647
-69% -$198K ﹤0.01% 6075
2022
Q4 		$146K Buy
420,797
+5,965
+1% +$2.42K ﹤0.01% 5798
2022
Q3 		$186K Sell
414,832
-240,350
-37% -$125K ﹤0.01% 5759
2022
Q2 		$261K Sell
655,182
-1,064,156
-62% -$475K ﹤0.01% 5763
2022
Q1 		$1.08M Sell
1,719,338
-109,402
-6% -$84.3K ﹤0.01% 4940
2021
Q4 		$2.03M Sell
1,828,740
-225,514
-11% -$348K ﹤0.01% 4573
2021
Q3 		$3.8M Buy
2,054,254
+1,098,753
+115% +$2.47M ﹤0.01% 4004
2021
Q2 		$3.03M Buy
955,501
+768,730
+412% +$1.92M ﹤0.01% 4282
2021
Q1 		$607K Buy
186,771
+153,621
+463% +$556K ﹤0.01% 5044
2020
Q4 		$21K Sell
33,150
-173
-0.5% -$79 ﹤0.01% 6425
2020
Q3 		$12K Sell
33,323
-61,091
-65% -$23.6K ﹤0.01% 6224
2020
Q2 		$51K Buy
94,414
+17,599
+23% +$8.49K ﹤0.01% 5673
2020
Q1 		$27K Sell
76,815
-41,562
-35% -$43.4K ﹤0.01% 5709
2019
Q4 		$174K Sell
118,377
-134,035
-53% -$466K ﹤0.01% 5468
2019
Q3 		$2.03M Buy
252,412
+140,954
+126% +$1.92M ﹤0.01% 3774
2019
Q2 		$1.97M Buy
111,458
+77,180
+225% +$1.69M ﹤0.01% 3781
2019
Q1 		$1.06M Sell
34,278
-25,442
-43% -$853K ﹤0.01% 4067
2018
Q4 		$1.75M Sell
59,720
-18,286
-23% -$831K ﹤0.01% 3875
2018
Q3 		$5.88M Buy
78,006
+19,246
+33% +$1.3M ﹤0.01% 3012
2018
Q2 		$3.33M Buy
58,760
+52,956
+912% +$1.93M ﹤0.01% 3599
2018
Q1 		$128K Sell
5,804
-7,210
-55% -$165K ﹤0.01% 5636
2017
Q4 		$327K Buy
13,014
+10,202
+363% +$314K ﹤0.01% 5206
2017
Q3 		$52K Sell
2,812
-5,439
-66% -$63.3K ﹤0.01% 5774
2017
Q2 		$76K Sell
8,251
-2,353
-22% -$22.4K ﹤0.01% 5736
2017
Q1 		$167K Sell
10,604
-8,788
-45% -$152K ﹤0.01% 5407
2016
Q4 		$328K Buy
19,392
+12,573
+184% +$258K ﹤0.01% 5146
2016
Q3 		$150K Sell
6,819
-1,098
-14% -$20.1K ﹤0.01% 5135
2016
Q2 		$126K Buy
7,917
+3,266
+70% +$103K ﹤0.01% 5141
2016
Q1 		$257K Buy
4,651
+3,601
+343% +$154K ﹤0.01% 4834
2015
Q4 		$33K Sell
1,050
-8,291
-89% -$267K ﹤0.01% 5873
2015
Q3 		$274K Buy
9,341
+8,691
+1,337% +$322K ﹤0.01% 4932
2015
Q2 		$25K Buy
650
+404
+164% +$18.6K ﹤0.01% 6080
2015
Q1 		$10K Sell
246
-1,296
-84% -$48.9K ﹤0.01% 6223
2014
Q4 		$59K Sell
1,542
-213
-12% -$8.79K ﹤0.01% 5761
2014
Q3 		$99K Sell
1,755
-200
-10% -$10.8K ﹤0.01% 5489
2014
Q2 		$128K Buy
+1,955
New +$113K ﹤0.01% 5384

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's ASXC Position: Q3 2024 in Review

Morgan Stanley sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 100,053 shares — an estimated $33.3K sold.

Morgan Stanley first reported a position in ASXC in Q2 2014 and held it in 41 quarters. The position peaked at $5.88M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Morgan Stanley reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Morgan Stanley sold 100,053 Asensus Surgical, Inc. shares in Q3 2024, an estimated $33.3K.
  • Morgan Stanley first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 41 quarters.
  • Morgan Stanley's Asensus Surgical, Inc. position peaked at $5.88M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.